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Abstract 
Background: Gram positive bacteria such Escherichia coli, Group B Streptococcus coagulase-negative 
staphylococci, Staphylococcus aureus, and Gram-negative bacteria such as Klebsiella and Pseudomonas species 
are listed as some of the bacteria etiologies for pediatric septicemia. These bacteria are rapidly becoming multi 
drug resistant to penicillin (or aminopenicillin), gentamicin, the pragmatic antibiotic treatment regimens.  Further, 
the ever-increasing burden of bacteria septicemia infection due to extended-spectrum β-lactamase (ESBL) 
producing Gram negative bacteria cumulatively presents a major health concern in the management and treatment 
of bacterial septicemia. In this study we present data on the prevalence and type of antimicrobial resistant patterns 
among children with bacterial septicemia in Mbita Sub county Hospital, Western region of Kenya. 
Methods: Blood samples were obtained from 248 children whose parents/guardian consented. The bacterial 
isolation and characterization were done using the automated BACTEC 9240 system, conventional culture using 
morphology, Gram stain and biochemical identification. Further identification and resistant gene detection were 
determined using Polymerase Chain Reaction (PCR). Descriptive statistics were used to present data.   
Results: Eighty-four (33.9%) patients had septicemia where Staphylococcus epidermidis (28.6%), S. aureus 
(13.1%), Escherichia coli (13.1%) and single Salmonella Paratyphi B, Citrobacter freundii, Gemella morbillorum, 
Klebsiella pneumoniae, Lactococcus lactis cremoris, Pantoea spp, and Pseudomonas putida were implicated. The 
majority of gram-negative bacteria were resistant to penicillin (Ampicillins) 100%, 96.1% to tetracyclin, 84.6% to 
sulphonamides (Trimethoprim/sulfamethoxazole), 73.1% Aminoglycosides (Gentamicin) 73.1% and 19.2% to 
Quinolone (Ciprofloxacin). For gram positive bacteria majority 96.7% were resistant to sulphonamides 
(Trimethoprim/sulfamethoxazole) followed by tetracycline 76.7%, penicillin (Oxacilline) 73.3% and least resistant 
to Quinolone (Ciprofloxacin) 30%. Various antimicrobial resistant genes mecA, SulII, blaTEM, TetA aac (3) were 
identified.  
Conclusion. In this geographically defined region of Kenya, of the 33.9% children with septicemia, gram positive 
bacteria were the leading cause septicemia. High level resistance due to various resistant genes were seen all type 
of antibiotics by both Gram positive and negative bacteria. Rapid antibiotic resistant testing is encouraged for 
appropriate treatment and management of septicemia infection. 
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Introduction 
Globally, bloodstream infections and sepsis are major causes of morbidity and mortality. Epidemiological data 
from high-income countries reported that 31.5 million cases of sepsis and 5.3 million sepsis attributable deaths 
occur annually (Fleischmann et al., 2015). Data from low-and-middle-income countries (Reinhart et al., 2017). 
Previous estimates, shows a range of 380 000–2 000 000 annual cases of neonatal sepsis in sub-Saharan Africa 
and 270 000 annual associated deaths, highlight the substantial burden of disease (Seale et al., 2010; Sepsis 
Alliance, 2016). Most studies on sepsis and bloodstream infections report an increasing incidence over the last two 
decades, particularly among the immunocompromised, multimorbid, and elderly patients, or due to failure of 
empiric antibiotic regimens as result of antimicrobial resistance (Goto & Al-Hasan, 2013; Cassini et al. 2019).  
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Children in developing countries are the most susceptible segment of the population, laying emphasis on the need 
for extraordinary consideration given that bloodstream infections and sepsis is the major cause of child mortality 
and morbidity (Kissoon et al., 2011). Invasive bacteria contribute largely to the etiologies of septicemia in African 
children (Jacob et al.,2009). Some of the bacteria etiologies for pediatric septicemia reported in varying prevalence 
in sub-Saharan Africa include Escherichia coli, Group B Streptococcus coagulase-negative staphylococci, 
Staphylococcus aureus, and Gram-negative organisms such as Klebsiella and Pseudomonas species (Zaidi et al., 
2009). The rapid spread of multi drug resistant bacterial pathogens is likely to complicate treatment of bacteria 
septicemia (Taxt et al., 2020). The widely embraced pragmatic antibiotic treatment regimens for sepsis based on 
penicillin (or aminopenicillin) in combination with gentamicin are faced with emergence of multidrug resistance 
jeopardizing their utility (Fuchs et al., 2018).  
 
Of importance, the ever-increasing burden of bacteria septicemia infection due to extended-spectrum β-lactamase 
(ESBL) producing Gram negative bacteria represents a major health concern (Taxt et al., 2020). These bacteria, 
mainly Escherichia coli and Klebsiella pneumoniae, are not only resistant to all penicillins and third generation 
cephalosporins, but also frequently express co-resistance to gentamicin (Taxt et al., 2020). Inevitably, treatment 
failure accompanied by increased treatment cost and fatality are likely to occur especially in developing nations. 
The increasing prescription of third and fourth generation - last-resort antibiotics such as carbapenems as initial 
antibiotic treatment of sepsis is likely to worsen sepsis management in developing nations most of which sell these 
antibiotics without the need for doctors’ prescription (Taxt et al., 2020). Increased emergence and spread of AMR 
are likely to be a big challenge in the near future especially in resource limited nations. Inevitably, rapid diagnosis 
of bacteria septicemia is crucial in the prescription of appropriate antimicrobial therapy likely to lower morbidity 
and mortality (Buehler et al., 2016). In this study we present data on the prevalence and type of antimicrobial 
resistant patterns among children with bacterial septicemia in Mbita Sub county Hospital, Western region of 
Kenya. 
METHODOLOGY 
Study setting and design 
This was a descriptive hospital based cross-sectional study conducted between 2019 and 2020 among children 
presenting with symptoms suggestive of septicemia as described by the WHO (Bataar et al., 2010), attending 
Mbita District Hospital in Nyanza Kenya. Using the formula for estimating the population proportion with 
specified relative precision described by Lemeshow et al (1990) setting the α at 0.05, and prevalence of bacterial 
septicemia of 76% (WHO, 2014), a total of 281 patients were recruited to achieve 0.95 power. 
 
Recruitment and ethical approvals 
This study recruited patients if: 1. Had clinical symptoms suggestive of septicemia as defined by the WHO. 2. 
Attending/admitted at Mbita District Hospital. 2. Age between 1 day to 120 months. 3. Parents/guardian providing 
informed consent. Study patients were then consecutively enrolled till the desired number was achieved. This study 
was approved by Ethical Review Committee of Kenyatta University before commencing to field activities. Each 
participant signed a form of informed consent 
 
Laboratory analysis 
Blood sample collection and transportation: From each of the participants enrolled, about 2-5ml (children) 
blood samples were collected aseptically in aerobic and anaerobic blood culture bottles BD (Becton Dickinson, 
US). The sampling bottles were appropriately labelled in line with pathological/request forms details i.e. name, 
sample code, date, time and location of the hospital and patients. The blood samples collected aseptically into 
appropriate blood culture tubes were packed in primary cases and secondary cases according to the WHO guideline 
for transporting infectious materials. The samples were maintained in upright position in a cooler box and 
transported to NUITM-KEMRI Biosafety level 2 laboratory at Mbita for processing. 
 
Microbiological analysis 
Samples were incubated at 370C for at least 3 weeks in the BACTEC 9270 (Becton Dickinson, US) automated 
machine. Generally, the BACTEC indicates signals for any positive culture wells. All positive culture bottle was 
taken to the Biosafety level III laboratory where they were sub cultured using sterile and disposable loops on basic, 
differential, selective media (Oxoid type) and other appropriate media like blood agar, chocolate blood agar 
(CBA), Xylose lysine deoxycholate (XLD), DHL, Salmonella–Shigella agar (SS), and Bromol thymol blue (BTB) 
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for other etiological agents. All plates were incubated at 37°C for 18-24hrs. Blood agar, Brucella agar and CBA 
were incubated in the presence of 5-10% CO2. The suspected colonies were examined and characterized by their 
morphology, Gram stain, biochemical identification (Sahin, et al., 2008). All the identified and clinically 
significant isolates were purified, accurately labelled and stored in 15-40% glycerol, at -800c for any future work 
or references.  
Antibiotic susceptibility testing 
Isolates were tested for their antimicrobial susceptibility by the Kirby-Bauer disk diffusion method according to 
the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2018). The drugs tested included; 
cefoxitin (CTX), streptomycin (STR), tetracycline (TET), Ampicillin (AMP), chloramphenicol (CHLO), 
ciprofloxacin (CIP), Nalidixic acid (NA), gentamicin (GEN), trimethoprim-sulfamethoxazole (SXT). The 
antimicrobial susceptibility was classified using the CLSI guidelines, as susceptible, intermediate, or resistant to 
each antibiotic. In addition, isolates were also classified as either non-susceptible (including both intermediate and 
resistant isolates) or susceptible. Isolates found to be non-susceptible or resistant to three or more antimicrobial 
categories were classified as multidrug resistant (MDR).  
Detection of resistant genes  
Plasmid DNA extraction: Profiling for R-plasmids and screening for the presence of previously reported 
resistance gene TetA gene, StrA gene Str B gene, Sul2gene, Amp C gene, Gyr A gene, CatA1 gene were done with 
modification as described by Szczepanowski et al., (2009). The representative of all bacterial isolates belonging 
to various antibiograms were selected and sub-cultured on Mueller-Hinton media overnight at 37°C and the 
plasmid DNA extracted using the alkaline lysis method described by Sambrook et al., (2001). Briefly, the plasmid 
DNA was extracted from 2-ml overnight cultures grown in Luria-Bertani (LB) broth (Difco Laboratories, Becton 
Dickinson, Sparks, MD). Plasmid sizes were determined using electrophoresis in comparison with plasmids from 
the reference strains E. coli V517 and E. coli 39R861 (Macrina, 1979). 
 
PCR and amplicon detection. The reaction mix of the PCR was composed of about 100 ng total plasmid DNA 
as template, 2.5 μl PuReTaq Ready-To-Go PCR beads and 0.5 μM of each primer (Table 1) and filled up to 25 μl 
with sterile double-distilled water. The PCR was performed using Bio-Rad iCycler Thermal Cycler (Champaign, 
US). The initial step of the reaction was denaturation of DNA at 94 °C for 4 min. This step was followed by 35 
cycles composed of 1 min denaturation at 94 °C, 1 min annealing at 58 °C and 45 s polymerization at 72 °C. The 
final polymerization step was performed for 10 min at 72 °C. The amplicons were analyzed by gel electrophoresis 
(in 1 % agarose in Tris/HCl/acetate buffer), stained with ethidium bromide and visualized under UV light. 
 
Data analysis 
Descriptive statistics frequencies (%), standard deviation, mean, and medians (interquartile ranges at 25% and 
27%) were used to present data.  Where applicable, test for significance was done using Fisher’s exact test or Chi-
square at the significance level of P 0.05. All statistical analyses were performed using STATA v 13 (StataCorp 
LP, College Station, TX, USA).  
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Table 1 gene identities, primer sequences, molecular sizes and the source 
 
Target Forward Reverse Size-
bp 
Reference 
StrA GCTGGATAGGTTAAGGGCGG  CTCTATGGGCACTGTCCACATTG  383 Hochhut et al., 
2001 
Sul2 AGGGGGCAGATGTGATCGAC  TGTGCGGATGAAGTCAGCTCC  625 Hochhut et al., 
2001 
TetA ATAAAATTCTTGAAGACGAAA GACAGTTACCAATGCTTAATC 1080 Weill et al., 2004 
CTX-
M 
AAA AAT GAT TGA AAG GTG GT CAG CGC TTT TGC CGT CTA AG  Karunakaran et al., 
2012 
CAtA1 AAGCGAACGA GGAAGTAAAA  Hochhut et al., 
2001 
AmpC AACACACTGATTGCGTCTGAC CTGGGCCTCATCGTCAGTTA 1870 peres-peres et al., 
2002 
Gyr A TTAATGATTGCCGCCGTCGG TACACCGGTCAACATTGAGG 648 Jaktaji & Mohiti, 
2010 
mecA GTA GAA ATG ACT GAA CGT 
CCGATAA 
CCA ATT CCA CAT TGT TTC 
GGTCTA A 
533 Wielders et al., 
2002 
StrA - Streptomycin resistance; Sul2 - sulfamethoxazole resistance; TetA - tetracycline resistance; CTX-M –
Ceftriaxone; CAtA1 gene – Chloramphenicol; AmpC- Augumentin; Gyr A – Ciprofloxacin; mecA Gene - 
Oxacillin/methicillin 
 
 
RESULTS 
Characteristics of study patients 
All the data was available for 248 out of recruited 281 children. The mean (± standard deviation - SD) age of the 
participants was 27.93 (±20.6) months with 30.6% of them aged between 1 to 12 months. The majority of the 
patients 50.8% were males, 48% from Rusinga locality and 91.9% HIV negative. The mean body temperature for 
the patients 38OC (± 20.5) ranging between 37 to 40OC. There were 58.9% patients with body temperatures above 
37.6 OC. The mean WBC of the patients was 17720.9 Cells/ml (± 8929.1) Cells/ml ranging between 12075 to 
22450 Cells/ml. about 25.4% of them had WBC above the normal levels of 10501 cells/ml. The mean respiratory 
rate (RR) of the patients was 30.6 (± 10.6) breaths/min ranging between 18 to 96 breaths/min with 71.4% having 
RR between 20 and 30 breaths/min. Co-infection/complications among the study patients included: malaria 
reported in 83 (33.5%) of the patients followed by respiratory illnesses 33 (13.3%), Hematologic diseases 
31(12.5%), Gastrointestinal disorders 27(10.9%), malnutrition and meningitis in 9 (3.6%) each. There were 6 
(2.4%) patients who had Nervous system diseases, 5(2.1%) with Ear nose and throat infections and 2 (0.8%) with 
HIV. There were 20 (8.1%) patients who reported no other co-infection. 
 
Etiology of septicemia among study patients 
 
A total of 18 different etiological agents were identified in this study from 84 of the 248 (33.9%) children who had 
septicemia. The most common causative agent of septicemia was Staphylococcus epidermidis (28.6%) followed 
by S. aureus and E. coli each at 13.1%. Others included P. aeroginosa (10.7%), S. typhimurium (8.3%), S. 
hemolyticus (4.8%) among others (Figure 1).  
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Figure 1: Frequency of etiological agents of septicemia among the study patients 
 
 
Antimicrobial resistant patterns of bacterial septicemia etiological agents 
Table 1 summarizes the drug susceptibility patterns for bacteria causing septicemia among study participants. 
Susceptibility testing showed that majority of gram-negative isolates were resistant to penicillin (Ampicillins) 
100% followed by tetracycline 96.1%, sulphonamides (Trimethoprim/sulfamethoxazole) 84.6%, Aminoglycosides 
(Gentamicin) 73.1% while they were least resistant to Quinolone (Ciprofloxacin) 19.2%. For gram positive 
bacteria majority 96.7% were resistant to sulphonamides (Trimethoprim/sulfamethoxazole) followed by 
tetracycline 76.7%, penicillin (Oxacilline) 73.3% and least resistant to Quinolone (Ciprofloxacin) 30%. 
 
Table 1: Distribution of drug susceptibility pattern of bacteria causing septicemia 
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Antibiotic class Antibiotic tested 
N % N % N %
Penicillins Ampicillin 0 0 0 0 26 100
Amoxicillin/Clavulanate 16 61.5 1 3.9 9 34.6
Cephalosporin Cefuroxime 7 26.9 1 3.9 18 69.2
Ceftriaxone 10 38.5 2 7.5 14 53.9
Tetracyclines Tetracycline 0 0 1 3.9 25 96.1
Quinolone Ciprofloxacin 20 76.9 1 3.9 5 19.2
Aminoglycosides Gentamicin 6 23.1 1 3.9 19 73.1
Sulfonamides Trimethoprim/sulfamethoxazole 3 11.5 1 3.9 22 84.6
Penicillins Oxacillin 8 26.7 0 0 22 73.3
 Amoxicillin/Clavulanate 14 46.7 0 0 16 53.3
Macrolides Erythromycin 16 53.3 0 0 14 46.7
Tetracyclines Tetracycline 6 20 1 3.3 23 76.7
Quinolone Ciprofloxacin 20 66.7 1 3.3 9 30
Aminoglycosides Gentamicin 14 46.7 4 13.3 12 40
Sulfonamides Trimethoprim/sulfamethoxazole 0 0 1 3.3 29 96.7
N - Frequency; % - Percentage
Drug susceptibility patterns for gram negative isolates
Sensitive Intermediate Resistant
Susceptibility pattern
Drug susceptibility patterns for gram positive isolates
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Drug resistant genes among the multi drugs resistant bacterial etiological agents 
The number of multi-drug resistant bacterial isolates included 4 Staphylococcus epidermidis, 4 S. aureus, 7 E. coli 
(4 Enterotoxigenic and 3 Enteropathogenic E. coli), 4 S. paratyphi (3 S. paratyphi A and 1 S. paratyphi B), 3 S. 
typhimurium and 3 P. aeruginosa 
 
S. aureus and S. epidermidis: Plasmids isolated from both S. epidermidis and S. aureus species harbored resistance 
genes, mecA and SulII, highlighting their role in dissemination of antibiotic resistance. High frequency of 
resistance was observed for Sulfamethoxazole-Trimethoprim (87.5%), Oxacilin (75.0%), Erythromycin (62.5%) 
and Amoxyclavulanic acid (50.0%). All the isolates were multiply resistant to between two to six antibiotics. One 
of the S. epidermidis did not carry any plasmid but showed phenotypic resistance to Oxacilin, Amoxyclavulanic 
acid, Sulfamethoxazole-Trimethoprim and Tetracycline (Table 2).  
 
E. coli: Plasmids isolated from the E. coli isolates studied harbored resistance genes, blaTEM, SulII, and TetA. 
High frequency of resistance was observed for Sulfamethoxazole-Trimethoprim (100%), Ampicillin (100%), 
Tetracycline (100%) and Gentamycin (85.7%). All the isolates were multiply resistant to between four and eight 
antibiotics. However, there was no apparent relationship between carriage of plasmids and antimicrobial resistance 
(Table 2). 
 
Table 2. Distribution of resistant genes among MDR S. epidermidis, S. aureus and pathogenic E. coli 
 
Where Ox- Oxacillin; Amoclav-Amoxicillin/Clavulanate; Sxt- Trimethoprim/sulfamethoxazole; Tet- 
Tetracycline; Ery-Erythromycin; Gen- Gentamicin; Cip- Ciprofloxacin; mec A-Methicillin-resistant 
Staphylococcus aureus; blaTEM - Nonspecific TEM β-Lactamase; TetA- Tetracycline Resistant gene A; SulII - 
Sulfonamide resistance gene 
 
Pseudomonas spp : The antimicrobial gene, blaTEM, was detected in five of the plasmids while four of the 
plasmids carried SulII, TetA and aac (3) antimicrobial resistance genes. High frequency of resistance was observed 
for Tetracycline (100%), Ampicillin (100%), Cefixime (80%), Cetriaxone (80%), Amoxyclavulanic acid (80.0%), 
Gentamicin (60.0%) and Sulfamethoxazole-Trimethoprim (60%), All the isolates were multiply resistant to 
between to two to six antibiotics.  
 
Salmonella spp: Plasmids isolated from the Salmonella isolates studied harbored resistance genes, blaTEM, SulII, 
aac (3) and TetA highlighting their role in transmission of resistance. High frequency of resistance was observed 
for Sulfamethoxazole-Trimethoprim (100%), Ampicillin (100%), Tetracycline (100%), Cefixime (100%), 
Gentamycin (100%) and Ceftriaxone (57.1%). All the isolates were multiply resistant to between to four to seven 
antibiotics. One of the Salmonella did not carry any plasmid but showed phenotypic resistance to Cefixime, 
Ampicillin, Sulfamethoxazole-Trimethoprim and Tetracycline. However, there was no apparent relationship 
between carriage of plasmids and antimicrobial resistance.  
 
 
Sample Isolate
No. of 
plasmids
Pattern of drug resistance 
Antimicrobial genes 
detected
1500 3000 4000 >10000
MDH/BLD/54 S. aureus 2 0 0 0 2 OX,  Amoclav, Sxt, Tet, Ery mecA
MDH/BLD/55 S. aureus 1 0 0 0 1 OX,  Gen, Tet, Ery mecA
MDH/BLD/15 S. aureus 1 0 0 0 1 Cip, Tet, Sxt, Ery SulII
MDH/BLD/135 S. aureus 1 0 0 0 1 OX, Sxt mecA
MDH/BLD/157 S. epidermidis 0 0 0 0 0 OX,  Amoclav, Sxt, Tet none
MDH/BLD/62 S. epidermidis 2 0 0 0 2 Amoclav,  Sxt,  Ery mecA
MDH/BLD/216 S. epidermidis 2 0 0 0 2 OX,  Cip,  Gen, Tet, Sxt mecA
MDH/BLD/104 S. epidermidis 2 0 0 0 2 OX,  Amoclav, Cip,  Sxt, Tet, Ery mecA
MDH/BLD/183 E. coli (EPEC) 3 1 1 0 1 Amp, Gen, Sxt, Tet blaTEM, SulII
MDH/BLD/222 E. coli (EPEC) 5 1 1 0 3 Amp, Amoclav, Gen, Sxt, Tet SulII,  TetA
MDH/BLD/229 E. coli (EPEC) 5 1 1 0 3 Amp, Gen, Sxt, Tet blaTEM, SulII, TetA
MDH/BLD/142 E. coli (ETEC) 4 1 1 0 2 Amp, Amoclav, Sxt, Tet blaTEM, SulII, TetA
MDH/BLD/163 E. coli (ETEC) 3 1 1 0 1 Amp, Gen, Sxt, Tet blaTEM, SulII, TetA
MDH/BLD/215 E. coli (ETEC) 3 1 1 0 1 Amp, Gen, Sxt, Tet blaTEM, SulII
MDH/BLD/156 E. coli (ETEC) 4 1 1 0 2 Amp, Amoclav, Cfm, Cfx, Gen, Cip, Sxt, Tet blaTEM, SulII, TetA
Approximate sizes of the 
plasmids (Kb)
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Table 3. Distribution of resistant genes among MDR S. paratyphi and S. typhimurium  
 
Where: Amp – Ampicillin; Cfm – Cefuroxime; Cfx – Ceftriaxone; Amoclav-Amoxicillin/Clavulanate; Sxt- 
Trimethoprim/sulfamethoxazole; Tet- Tetracycline; Gen- Gentamicin; Cip- Ciprofloxacin; blaTEM - Nonspecific 
TEM β-Lactamase; TetA- Tetracycline Resistant gene A; SulII - Sulfonamide resistance gene; aac(3) - 
Aminoglycoside acetyltransferase gene 
 
 
Discussions 
Early diagnosis and early appropriate treatment are crucial in cases of bacterial blood infection. In severe sepsis, 
the case fatality increases for each hour the antibiotic treatment is delayed (Ferrer et al., 2014). Therefore, empirical 
antibiotic treatment has to be initiated before the results of blood cultures are available. However, as infections 
with resistant microbes is an escalating problem worldwide, it is increasingly challenging to maintain appropriate 
antibiotic regimens for initial empiric therapy (Nathan and Cars, 2014; WHO, 2014). Resistant pathogenic bacteria 
are found frequently worldwide (WHO, 2014). Studies have shown that most developing countries are home to a 
number of risk factors for the emergence and spread of antibiotic resistance. Misuse of antibiotics, over-the-counter 
and parallel market access, and counterfeit or poor-quality drugs, combined with substandard hygiene and living 
conditions, are the driving forces behind the emergence and spread of antibiotic resistance (Kelesidis et al., 2007). 
The potential for the development and rapid spread of new forms of resistance is highlighted by the recent 
worldwide proliferation of NDM-1-producing Enterobacteriaceae. The gene, which confers resistance to 
carbapenems, originated in India in 2009, and since 2010 NDM-1-producing Enterobacteriaceae have been 
reported in North America, Europe, and Asia (Kumarasamy et al., 2010). The WHO has recently heightened 
awareness of this pressing issue with calls for action to contain antibiotic resistance on a global scale (WHO, 
2014). In Kenya, a regimen containing penicillin and gentamicin, plus metronidazole if an anaerobic infection is 
suspected, has been recommended for more than thirty years in sepsis with unknown focus and etiology (Lee et 
al., 2014). In recent years, however, increasing numbers of infections with methicillin-resistant S. aureus (MRSA), 
extended-spectrum beta-lactamase producing Enterobacteriaceae, and vancomycin resistant enterococci have 
been detected (Lee et al., 2014). Selection of inherently resistant microbes due to antibiotic use is also a challenge. 
Updated knowledge about the distribution of microbes in serious infection and their resistance against 
antimicrobial agents is needed to ensure appropriate empiric antimicrobial treatment regimens. It is also important 
to identify subgroups in which tailored regimens are required. This was the basis important aspect of this study 
 
S. aureus 
The three out of four S. aureus isolates causing septicemia had the mecA antimicrobial gene while one carried 
SulII antimicrobial gene. One of the four isolates were multi-drug resistant to five different drugs (Oxacillin, 
Amoxicillin/Clavulanate, Trimethoprim/sulfamethoxazole, Tetracycline and Erythromycin). Two isolates were 
resistant to four different drugs and one isolate to two different drugs. Our study further shows that 75% of the S. 
aureus were Methicillin resistance. The S. aureus with varying antibiotic profiles have been associated with sepsis 
in other settings. In Kilifi District Hospital on the Kenyan coast Talbert et al., (2010) reported that all the 
Staphylococcus aureus blood culture isolates were susceptible to methicillin. The S. aureus causing neonatal sepsis 
in Tikur Anbessa University Hospital, Ethiopia; showed high-level resistance to ampicillin, cefiriaxone, 
cephalothin, chloramphenicol, and gentamicin (Shitaye et al., 2010). In Pakistan, Mir et al., (2011) all the 4.2% 
reported S. aureus were methicillin-resistant S. aureus (MRSA). Dramowski et al., (2015) the S. aureus etiology 
of septicemia 65% of them were Methicillin-resistant. About 40% of all lethal cases of sepsis caused by 
Staphylococcus spp among children admitted at the Hospital, affiliate of Vilnius University Hospital in in 
Sample Isolate
No. of 
plasmids
Pattern of drug resistance Antimicrobial genes detected
1500 3000 4000 >10000
MDH/BLD/093 S. paratyphi  B 4 0 1 1 2 Amp, Cfm, Gen, Sxt, Tet blaTEM, SulII, TetA, aac(3)
MDH/BLD/219 S. paratyphi  A 3 0 1 1 1 Amp, Cfm,  Cfx, Gen, Sxt, Tet blaTEM, SulII, TetA, aac(3)
MDH/BLD/238 S. paratyphi  A 5 0 1 1 3 Amp, Cfm, Cfx, Gen, Sxt, Tet blaTEM, SulII, TetA, aac(3)
MDH/BLD/203 S. paratyphi  A 3 0 1 1 1 Amp, Cfm, Cfx, Gen, Sxt, Tet blaTEM, SulII, TetA, aac(3)
MDH/BLD/133 S. Typhimurium 0 0 0 0 0 Amp, Cfm, Gen, Sxt, Tet -
MDH/BLD/134 S. Typhimurium 5 0 1 1 3 Amp, Cfm, Gen, Sxt, Tet blaTEM, SulII, TetA, aac(3)
MDH/BLD/189 S. Typhimurium 3 0 1 1 1 Amp, Cfm, Cfx, Gen,  Sxt, Tet SulII, TetA, aac(3)
MDH/BLD/11 P. aeruginosa 1 0 0 0 1 Amp, Amoclav, Cfm, Cfx, Cip, Sxt, Tet blaTEM, SulII, TetA, aac(3)
MDH/BLD/4 P. aeruginosa 2 0 0 0 2 Amp, Amoclav,  Cfx, Gen,  Sxt, Tet blaTEM, SulII, TetA, aac(3)
MDH/BLD/8 P. aeruginosa 2 0 0 0 2 Amp, Amoclav, Cfm, Cfx,  Cip, Tet blaTEM, SulII, TetA 
MDH/BLD/35 P. aeruginosa 1 0 0 0 1 Amp, Cfm, Cfx, Gen, Sxt, Tet blaTEM, aac(3)
MDH/BLD/175 P. aeruginosa 1 0 0 0 1 Amp, Amoclav, Cfm, Gen, Cip, Tet blaTEM, SulII, TetA, aac(3)
Approximate sizes of the 
plasmids
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Lithuania was resistant to Methicillin (Bobelytė, 2017). Our study and other showing significantly high prevalence 
of multidrug resistant S. aureus is worrying given bacteraemias due S. aureus are difficult to treat and is associated 
with 29–63% mortality (Kaasch et al., 2014; Fortuin-de Smidt et al., 2015). The emergence of new CA-MRSA 
strains in the community has huge implications on patient treatment (David et al., 2010).  
 
S. epidermidis 
There were 3 out of 4 (75%) S. epidermidis that had antimicrobial gene, mecA and only one isolate did not carry 
any plasmid. All four S. epidermidis were resistant to 3 to 6 different antibiotics. The strain that had no plasmid 
containing antimicrobial gene, mecA showed phenotypic resistance to Oxacilin, Amoxyclavulanic acid, 
Sulfamethoxazole-Trimethoprim and Tetracycline. Studies continue to report the importance of Coagulase-
negative staphylococci as among the leading cause of nosocomial sepsis, especially in neonates (Marchant et al., 
2013; Becker et al., 2014). Coagulase-negative staphylococci sepsis most often originates from the infection of 
indwelling medical devices, such as in catheter-related bloodstream infections or central line-associated blood 
stream infections (Vassallo et al., 2015). Most prominent among Coagulase-negative staphylococci infections are 
those due to the skin commensal S. epidermidis (Vassallo et al., 2015). However, the bacterial factors contributing 
to the development of sepsis, in particular in CNS, are poorly understood. Most S. epidermidis blood infections 
are caused by methicillin-resistant strains, with methicillin resistance rates even exceeding those found among S. 
aureus (Qin et al., 2017).  
 
Methicillin-resistant S. epidermidis isolates from patients are cross-resistant to all b-lactam antibiotics, even 
though some might be susceptible to certain b-lactam agents by in vitro testing (Raad et al., 1998). Therefore, this 
pattern of resistance is similar to what has already been established with methicillin-resistant S. aureus. The 
prevalence of resistance has increased rapidly over the last three decades and has been attributed to the selection 
effect of the increasing use of b-lactam antibiotics. Studies have demonstrated an increase in the prevalence of 
resistant S. epidermidis in hospitals when isolates from 1964 were compared with isolates from 1986 or resistance 
and plasmid profiles (Raad et al., 1998). This resistance was plasmid-mediated. Some investigators attributed 
resistance in S. epidermidis to the action of the mecA gene (Raad et al., 1998). However, Mempel et al., (1994) 
demonstrated that S. epidermidis isolates could be methicillin resistant and lack mecA transcription. 
 
E. coli 
The seven pathogenic E. coli species harbored three types of antimicrobial gene, SulII, blaTEM and TetA. One 
pathogenic ETEC was resistant to 8 different antibiotics, 3 ETEC were multi-drug resistant to 4 different 
antibiotics. One EPEC was resistant to 5 different antibiotics while the remaining 2 EPEC were resistant to four 
different antibiotics. Similar studies exist showing high level antibiotic resistance to E. coli species isolated from 
neonatal septicemia cases. Studies showed resistance to penicillin/ampicillin ranging from 55% among E. coli 
isolates in Georgia (Macharashvili et al., 2009) to 100% among E. coli isolates in Uganda (Mugalu et al., 2006). 
Resistance to gentamicin among E. coli ranged from 0% in Pakistan (Mir et al., 2011), 21.7% in South Africa 
(Dramowski et al., 2015), 67 in India (Jyothi et al., 2013). In Lithuania, sepsis-causing pathogens E. coli was 
characterized by the development of increasing antibiotic resistance for which initial empirical antibiotic therapy 
might fail (Bobelytė et al., 2017). Resistant to third generation cephalosporins ranged from 6% for E. coli isolates 
in Uganda (Mugalu et al., 2006) to 48% in India (Jyothi et al., 2013). Concerning the extended spectrum beta-
lactamase production in Enterobacteriaceae; one reported extended spectrum beta-lactamase production in 65% 
of E. coli isolates (Jain et al., 2006). In India a study among pediatrics sepsis patients attending Majeedia Hospital 
of Hamdard University in New Delhi showed various resistance profile of E. coli including: ampicillin (92%), 
amoxicillin (90.9%), amoxiclav (68.4%), cefuroxime (54.5%), cefaclor (84.2%), cefotaxime (52.9%), 
cefoperazone (36.8%), gentamicin (19%), amikacin (12%), netilmicin (13%), ciprofloxacin (26.1%), 
chloramphenicol (16.7%) and tetracycline (44.4%) (Alam et al., 2011). In Pakistan Ullah et al., (2016) reported 
higher level of antibiotic resistance among E. coli isolates including third line antibiotics; Amikacin 58%, 
Ciproflaxacin 67.3%, Enoxacin 83.3%, Imipenem 94.7% and Ofloxacin 77.7%. In Ghana, Obeng-Nkrumah et al. 
(2016) reported various antibiotic resistance among E. coli isolates including ampicillin (97.7%), amoxicillin 
clavulanic acid (53.5%), gentamicin (53.5%) and ciprofloxacin (62.1%).  
 
Salmonella spp  
Six out of seven Salmonella species studied were found carrying at least three plasmids of varying sizes. 
Antimicrobial gene, SulII, was detected in the six Salmonella isolates while aac (3), TetA and blaTEM genes were 
detected in five Salmonella isolates. One of the Salmonella did not carry any plasmid but showed phenotypic 
resistance to Cefixime, Ampicillin, Sulfamethoxazole-Trimethoprim and Tetracycline. There was one Salmonella 
paratyphi B that was multi-resistant to five different antibiotics, three Salmonella paratyphi A were multi-resistant 
to six different antibiotics. Further, there were two and one Salmonella typhimurium that were multi-resistant to 
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five and six different antibiotics respectively. Generally high frequency of resistance was observed for 
Sulfamethoxazole-Trimethoprim (100%), Ampicillin (100%), Tetracycline (100%), Cefixime (100%), 
Gentamycin (100%) and Ceftriaxone (57.1%). Studies confirms that the invasive forms of Salmonella disease 
include enteric fevers (typhoid and paratyphoid fevers) and NTS bacteraemia and are important causes of 
morbidity and mortality in Asia and Africa (Smith et al., 2014). In India a study among pediatrics sepsis patients 
attending Majeedia Hospital of Hamdard University in New Delhi showed various resistance profile in Salmonella 
typhi to various antimicrobials as follows ampicillin (46.4%), amoxicillin (27.3%), amoxiclav (15.4%), 
cefuroxime (10%), cefotaxime (25%), cefoperazone (10.5%), netilmicin (10.5%), ciprofloxacin (6.3%), 
chloramphenicol (9.1%) and tetracycline (37%). Salmonella typhi did not show resistance to gentamicin and 
amikacin (Alam et al., 2011). On the other hand, in the same study Salmonella paratyphi A did not show resistance 
to antimicrobials tested (Alam et al., 2011). In Pakistan Ullah et al., (2016) reported higher level of antibiotic 
resistance among Salmonella spp including third line antibiotics Amikacin 100%, Ciproflaxacin 66.7%, Enoxacin 
66.7%, Imipenem 66.7% and Ofloxacin 83.3%.  In Ghana, Obeng-Nkrumah et al. (2016) reported various 
antibiotic resistance among Salmonella spp including ampicillin (63.9%) and amoxicillin clavulanic acid (23.9%). 
In Zanzibar, the majority of the S. Typhi isolates 6/7 (86%) were multidrug-resistant (i.e. resistant to ampicillin, 
trimethoprim-sulfamethoxazole and chloramphenicol), but susceptible to cefotaxime (Onken et al., 2015).  
 
Pseudomonas spp  
The antimicrobial gene, blaTEM, was detected in five of the Pseudomonas plasmids while four of the plasmids 
carried SulII, TetA and aac (3) antimicrobial resistance genes. High frequency of resistance was observed for 
Tetracycline (100%), Ampicillin (100%), Cefixime (80%), Cetriaxone (80%), Amoxyclavulanic acid (80.0%), 
Gentamicin (60.0%) and Sulfamethoxazole-Trimethoprim (60%), All the isolates were multiply resistant to 
between to two to six antibiotics. These results were similar to those in other studies; In India Alam et al., (2011) 
among pediatrics sepsis patients attending Majeedia Hospital of Hamdard University in New Delhi showed various 
resistance profile in Pseudomonas spp including: ampicillin (93.8%), amoxicillin (93.3%), amoxiclav (90.9%), 
cefuroxime (75%), cefotaxime (46.2%), cefazidime (38.5%), cefoperazone (42.9%), gentamicin (33.3%), 
amikacin (11.8%), netilmicin (23.1%), ciprofloxacin (20%), ofloxacin (20%), chloramphenicol (40%) and 
tetracycline (36.4 %). In Ghana, Obeng-Nkrumah et al. (2016) reported various antibiotic resistance among 
Pseudomonas spp gentamicin (32.8%), ampicillin (13.1%), ciprofloxacin (19.6%). In Pakistan Mir et al., (2011) 
reported no resistance to antibiotics including gentamicin among Gram-negative bacteria including Pseudomonas 
and E. coli. In Vietnam 56% of the sepsis causing Pseudomonas isolates were resistant to carbapenem resistant 
(Le et al., 2016). In Turkey, Pseudomonas spp which was the major causative pathogens of sepsis in children was 
40.5% resistant to imipenem (Teke et al., 2016). Evaluation of the trends in antimicrobial resistance of bloodstream 
infections at a general hospital in Mid-Norway, showed, Pseudomonas spp were 100% resistant to cefotaxim and 
6.9% to Imipenem (Mehl et al., 2017).  
 
In conclusion, in this geographically defined region of Kenya, of the 33.9% children with septicemia, gram positive 
bacteria were the leading cause septicemia. Specifically, S. epidermidis and S. aureus. However, several other 
Gram-negative bacteria were implicated such as E. coli, P. aeruginosa, S. typhimurium and S. hemolyticus. It 
should be noted that gram-negative bacteria have often been implicated in the pathogenesis of severe sepsis and 
septic shock than the Gram-positive counter parts (Alexandraki and Palacio, 2010). Compared to Gram positive, 
majority of Gram-negative bacteria were resistant to penicillin (Ampicillins) 100% tetracycline 96.1%, 
sulphonamides (Trimethoprim/sulfamethoxazole) 84.6%, Aminoglycosides (Gentamicin) 73.1% and least 
resistant to Quinolone (Ciprofloxacin) 19.2%. The Gram-positive bacteria were resistant to sulphonamides 
(Trimethoprim/sulfamethoxazole) 96.7%, tetracycline 76.7%, penicillin (Oxacilline) 73.3% and Quinolone 
(Ciprofloxacin) 30%. The following antimicrobial resistant genes mecA, SulII, blaTEM, TetA aac (3) were 
identified However, we did not find apparent relationship between carriage of plasmids and antimicrobial 
resistance.  
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